Platelet-fibrinogen interactions

Annals of the New York Academy of Sciences

Volumn 936, Issue , 2001, Pages 340-354

  Bennett, Joel S ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BRB II/III   (United States)

Author keywords

Fibrinogen receptors; GPIIb IIIa; Platelet aggregation; RGD peptides

Indexed keywords

ACTIN; CREATINE KINASE; CREATINE PHOSPHATE; CYTOCHALASIN D; DEOXYGLUCOSE; FIBRINOGEN; FIBRINOGEN RECEPTOR AFFECTING AGENT; JASPAMIDE; LATRUNCULIN A; TRITON X 100;

ACTIN FILAMENT; AFIBRINOGENEMIA; ALLOSTERISM; ALPHA CHAIN; AMINO TERMINAL SEQUENCE; ARTERY THROMBOSIS; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; CROSS LINKING; ELECTRON MICROSCOPY; THROMBOCYTE; THROMBOCYTE AGGREGATION;

EID: 0034969359     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03521.x     Document Type: Conference Paper

References (71)

1. Fibrinogen and adenosine diphosphate-induced aggregation of platelets
2. Effect of fibrinogen on the aggregation of platelets by adenosine diphosphate
3. Fibrinogen and platelets in the primary arrest of bleeding
4. Exposure of platelet fibrinogen receptors by ADP and epinephrine
5. Human platelets possess an inducible and saturable receptor specific for fibrinogen
6. Glanzmann thrombasthenia; deficient binding of von Willebrand factor to thrombin-stimulated platelets
7. Chromosomal localization of the genes for the vitronectin and fibronectin receptors α subunits and for platelet glycoproteins IIb and IIIa
8. Integrins: A family of cell surface receptors
9. GPIIb-IIIa: The responsive integrin
10. Structural biology of glycoprotein IIb-IIIa
11. Molecular basis for platelet activation
12. Integrin signaling: The platelet paradigm
13. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors
14. On the role of the platelet membrane skeleton in mediating signal transduction
15. The cytoskeleton of the resting human blood platelet: Structure of the membrane skeleton and its attachment to actin filaments
16. Mechanisms of actin rearrangements mediating platelet activation
17. 3 for fibrinogen
18. Inhibition of actin polymerization in blood platelets by cytochalasin
19. Identification of the ADP receptor targeted by antithrombotic drugs
20. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin
21. 2+
22. Platelet membrane glycoprotein IIb/IIIa: Member of a family of arg-gly-asp-specific adhesion receptors
23. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets
24. Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationships of peptides corresponding to the carboxy-terminal segment of the g chain
25. Examination of the platelet membrane glycoprotein IIb/IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy
26. Structure of human platelet membrane glycoproteins IIb and IIIa as determined by electron microscopy
27. A model for fibrinogen: Domains and sequence
28. Role of fibrinogen α and γ chain sites in platelet aggregation
29. Binding of recombinant fibrinogen mutants to platelets
30. The residues AGDV of recombinant γ chains of human fibrinogen must be carboxyl-terminal to support human platelet aggregation
31. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells
32. Interaction of fibrinogen with its platelet receptor. Differential effects of α and γ chain fibrinogen peptides on the glycoprotein IIb-IIIa complex
33. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen gamma chain peptides share a common binding site on platelets
34. Competition for related but nonidentical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from platelet adhesive proteins
35. Identification of a region in the integrin β3 subunit that confers ligand binding specificity
36. Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor
37. A β3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation
38. Ligand binding to integrin αIIbβ3 is dependent on a MIDAS-like domain in the β3 subunit
39. Mutation of a ligand binding domain of beta 3 integrin. Integral role of oxygenated residues in alpha IIb beta 3 (GPIIb-IIIa) receptor function
40. Inhibition of fibrinogen binding to GPIIb-IIIa by a GP IIIa peptide
41. Peptides derived from a sequence within beta 3 integrin bind to platelet alpha IIb beta 3 (GPIIb-IIIa) and inhibit ligand binding
42. 214Trp mutation
43. A spontaneous mutation of integrin αIIb β3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site
44. Activation of the fibrinogen binding site on platelets isolated from a patient with the Strasbourg I variant of Glanzmann's thrombasthenia
45. 3 complex that binds fibrin but not fibrinogen
46. Sequence 274-368 in the β3 subunit of the integrin αIIbβ3 provides a ligand recognition and binding domain of the γ-chain of fibrinogen that is independent of platelet activation
47. 3
48. The ligand binding site of the platelet integrin receptor GPIIb-IIIa is proximal to the second calcium binding domain of its α subunit
49. A peptide corresponding to GPIIb alpha 300-312, a presumptive fibrinogen gamma-chain binding site on the platelet integrin GPIIb/IIIa, inhibits the adhesion of platelets to at least four adhesive ligands
50. Glycoprotein IIb Leu214Pro mutation produces Glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa
51. Critical residues of integrin αIIb subunit for binding of αIIbβ3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3)
52. A mutation in the α subunit of the platelet integrin αIIbβ3 identifies a novel region important for ligand binding
53. A naturally occurring mutation near the amino terminus of αIIb defines a new region involved in ligand binding to αIIbβ3
54. Folding of the N-terminal, ligand-binding region of integrin alpha-subunits into a beta-propeller domain
55. Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin αIIbβ3
56. Ligand and cation binding are dual functions of a discrete segment of the integrin β3 subunit: Cation displacement is involved in ligand binding
57. Characterization of cation-binding sequences in the platelet integrin GPIIb-IIIa (αIIbβ3) by terbium luminescence
58. Effects of cell adhesion peptide, Arg-Gly-Asp-Ser, on responses of washed platelets from humans, rabbits, and rats
59. Structure of the platelet membrane glycoprotein IIb
60. Structure of platelet glycoprotein IIIa
61. A comparative analysis of cDNA-derived sequences for rat and mouse beta 3 integrins (GPIIIA) with their human counterparts
62. Characterization of the murine platelet αIIb gene and encoded cDNA
63. Platelet aggregation caused by dithiothreitol
64. IIb
65. 3
66. Ultrastructure of clots during isometric contraction
67. Platelets interact with fibrin only after activation
68. Peptides and monoclonal antibodies which bind to platelet glycoproteins IIb and/or IIIa inhibit clot retraction
69. Dissecting clot retraction and platelet aggregation
70. The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction
71. Spreading of platelets on fibrin is mediated by the amino terminus of the β chain including peptide β15-42